Mucormycosis is a difficult to diagnose rare disease with high morbidity and mortality.
Diagnosis is often delayed, and disease tends to progress rapidly. Urgent surgical and medical …

Objectives Candidaemia is a serious hazard to hospitalized patients, but European
epidemiological data are restricted to national studies focusing on Northern Europe, population-…

Mucormycosis is an emerging invasive fungal infection, primarily affecting immunocompromised
patients. The disease is difficult to diagnose and mortality reaches 40% even if treated …

The European Society for Clinical Microbiology and Infectious Diseases, the European
Confederation of Medical Mycology and the European Respiratory Society Joint Clinical …

Scope In 2009, the European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
published the first treatment guidance document for Clostridioides difficile infection (CDI…

Coronavirus in Travelers Returning from China A group of 126 German nationals was evacuated
from Wuhan to Frankfurt after screening for symptoms of Covid-19 and was to undergo …

Background Mucormycosis is an uncommon invasive fungal disease with high mortality and
few treatment options. Isavuconazole is a triazole active in vitro and in animal models …

Cardiac symptoms are increasingly recognized as late complications of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection in previously well individuals with mild …

The SARS-CoV-2 pandemic has unprecedented implications for public health, social life,
and the world economy. Because approved drugs and vaccines are limited or not available, …

CD4 + T cells reactive against SARS-CoV-2 can be found in unexposed individuals, and these
are suggested to arise in response to common cold coronavirus (CCCoV) infection. Here, …